January 30, 2019
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)
Read More
January 30, 2019
Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)
Read More
December 10, 2018
Combination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia (CLL) That Did Not Respond to Fludarabine, CLL With Autoimmune Haemolytic Anemia (AIHA) or Richter’s Transformation (RT)
Read More
December 10, 2018
Home Therapy With Replagal in Fabry Disease
Read More
December 10, 2018
Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab
Read More
December 10, 2018
Therapy Optimisation for the Treatment of Hairy Cell Leukemia
Read More
December 10, 2018
ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma
Read More
December 10, 2018
Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia
Read More
X